CIK 0001427925 · Non-accelerated filer<br>Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 412193603
- Phone
- 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-03 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −398 | $1.31 | $521 | 18,771 |
| 2023-03-03 | Palmer Pamela P Chief Medical Officer | Shares withheld for taxes | −570 | $1.31 | $747 | 43,315 |
| 2023-03-03 | ASADORIAN RAFFI Chief Financial Officer | Shares withheld for taxes | −510 | $1.31 | $668 | 22,081 |
| 2023-03-03 | Angotti Vincent J. Chief Executive Officer | Shares withheld for taxes | −1,703 | $1.31 | $2K | 63,836 |
| 2023-02-11 | Palmer Pamela P Chief Medical Officer | Shares withheld for taxes | −1,017 | $1.68 | $2K | 43,885 |
| 2023-02-11 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −776 | $1.68 | $1K | 19,169 |
| 2023-02-11 | ASADORIAN RAFFI Chief Financial Officer | Shares withheld for taxes | −873 | $1.68 | $1K | 22,591 |
| 2023-02-11 | Angotti Vincent J. Chief Executive Officer | Shares withheld for taxes | −3,321 | $1.68 | $6K | 65,539 |
| 2023-02-10 | Palmer Pamela P Chief Medical Officer | Grant or award | +6,125 | 44,902 | ||
| 2023-02-10 | Palmer Pamela P Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +36,750 | 36,750 | ||
| 2023-02-10 | Dasu Badri N Chief Engineering Officer | Grant or award | +4,875 | 19,945 | ||
| 2023-02-10 | Dasu Badri N Chief Engineering Officer | Grant or award · Stock Option (Right to Buy) | +29,250 | 29,250 | ||
| 2023-02-10 | ASADORIAN RAFFI Chief Financial Officer | Grant or award | +5,875 | 23,464 | ||
| 2023-02-10 | ASADORIAN RAFFI Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +35,250 | 35,250 | ||
| 2023-02-10 | Angotti Vincent J. Chief Executive Officer | Grant or award | +19,500 | 68,860 | ||
| 2023-02-10 | Angotti Vincent J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +117,000 | 117,000 | ||
| 2023-02-06 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −458 | $2.02 | $925 | 15,070 |
| 2023-02-06 | ASADORIAN RAFFI Chief Financial Officer | Shares withheld for taxes | −617 | $2.02 | $1K | 17,589 |
| 2023-02-06 | Palmer Pamela P Chief Medical Officer | Shares withheld for taxes | −681 | $2.02 | $1K | 38,777 |
| 2023-02-06 | Angotti Vincent J. Chief Executive Officer | Shares withheld for taxes | −1,982 | $2.02 | $4K | 49,360 |
Page 8 of 9 · 179 trades